BIOPSY BONE MARROW ABNORMAL side effect
What is BIOPSY BONE MARROW ABNORMAL ?Drugs associated with BIOPSY BONE MARROW ABNORMAL
ACTOS CIPRO CLARITHROMICINA CLOMIPHENE COMBIVIR CYTARABINE DIOVAN IMATINIB ISENTRESS NATALIZUMAB NEULASTA NOVANTRONE PROGRAF REVLIMID THALIDOMIDE VOLTAREN ZOMETABIOPSY BONE MARROW ABNORMAL : Isentress Side Effects Report #5623712-0
Physician from UNITED STATES reported ISENTRESS problem on Jan 24, 2008. Male patient, 50 years of age, weighting 154.0 lb, was diagnosed with hiv infection and was treated with ISENTRESS. After drug was administered, patient experienced the following problems/side effects: biopsy bone marrow abnormal, blood creatine increased, blood urea increased, haematocrit decreased, haemoglobin decreased, hypersensitivity, immune reconstitution syndrome, nephritis interstitial, platelet count decreased, . ISENTRESS dosage: 400MG/BID/PO. During the same period patient was treated with SUSTIVA, EPIVIR, VIDEX EC, ANDROGEL, DIFLUCAN, MEPRON, OXANDRIN, PROCRIT. Patient was hospitalized. Patient recovered.
BIOPSY BONE MARROW ABNORMAL : Combivir Side Effects Report #5602541-8
COMBIVIR problem was reported by a Consumer or non-health professional from SPAIN on Jan 17, 2008. Male patient, 49 years of age, was diagnosed with hiv infection, abdominal discomfort and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: biopsy bone marrow abnormal, refractory anaemia with an excess of blasts, . COMBIVIR dosage: unknown. During the same period patient was treated with OMEPRAZOLE, ACYCLOVIR, METHADONE, VIREAD. Patient was hospitalized. Patient recovered.
BIOPSY BONE MARROW ABNORMAL : Diovan Side Effects Report #5519198-7
Consumer or non-health professional from UNITED STATES reported DIOVAN problem on Nov 12, 2007. Male patient, 63 years of age, weighting 319.9 lb, was diagnosed with hypertension and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: biopsy bone marrow abnormal, fatigue, leukaemia, white blood cell count increased, . DIOVAN dosage: unknown. During the same period patient was treated with ZESTRIL, CITALOPRAM HYDROBROMIDE, MELOXICAM. Patient recovered.
BIOPSY BONE MARROW ABNORMAL : Prograf Side Effects Report #5419986-1
PROGRAF problem was reported by a Physician from JAPAN on Aug 06, 2007. Male patient, 41 years of age, was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: biopsy bone marrow abnormal, cerebral atrophy, encephalitis herpes, human herpesvirus 6 infection, . PROGRAF dosage: unknown. Patient recovered.
BIOPSY BONE MARROW ABNORMAL : Novantrone Side Effects Report #5421458-5
Consumer or non-health professional from UNITED STATES reported NOVANTRONE problem on Aug 08, 2007. Female patient, 66 years of age, weighting 116.0 lb, was diagnosed with acute myeloid leukaemia and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: biopsy bone marrow abnormal, cardiac arrest, disease progression, dyspnoea, ejection fraction decreased, electrolyte imbalance, electromechanical dissociation, febrile neutropenia, fluid overload, . NOVANTRONE dosage: unknown. During the same period patient was treated with ETOPOSIDE, ACYCLOVIR, ALLOPUINOL, CALCIUM CARBONATE, CEFEPIME, NYSTATIN, PROTONIX. Patient was hospitalized. Patient recovered.
BIOPSY BONE MARROW ABNORMAL : Actos Side Effects Report #5379449-9
ACTOS problem was reported by a Physician from UNITED STATES on June 25, 2007. Male patient, 66 years of age, weighting 175.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with ACTOS. After drug was administered, patient experienced the following problems/side effects: biopsy bone marrow abnormal, pancytopenia, weight decreased, . ACTOS dosage: 30 MG, 1 IN 1 D, PER ORAL. During the same period patient was treated with AMARYL, ULTRACET, CYCLOBENZAPRINE. Patient died.
BIOPSY BONE MARROW ABNORMAL : Actos Side Effects Report #5379449-9
Physician from UNITED STATES reported ACTOS problem on June 25, 2007. Male patient, 66 years of age, weighting 175.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with ACTOS. After drug was administered, patient experienced the following problems/side effects: biopsy bone marrow abnormal, pancytopenia, weight decreased, . ACTOS dosage: 30 MG, 1 IN 1 D, PER ORAL. During the same period patient was treated with AMARYL, ULTRACET, CYCLOBENZAPRINE. Patient died.
BIOPSY BONE MARROW ABNORMAL : Natalizumab Side Effects Report #5535051-7
NATALIZUMAB problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 20, 2007. Female patient, 62 years of age, weighting 170.4 lb, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, biopsy bone marrow abnormal, blepharitis, blood albumin decreased, cardiac aneurysm, cognitive disorder, condition aggravated, conjunctival hyperaemia, culture urine positive, . NATALIZUMAB dosage: 300 MG;QM;IV. During the same period patient was treated with NEUTONTIN, DETROL, MIRAPEX, VYTORIN, SYNTHROID, HYDROCHLOROTHIAZIDE, FOSAMAX, DARVOCET. Patient was hospitalized. Patient recovered.
BIOPSY BONE MARROW ABNORMAL : Imatinib Side Effects Report #5549550-5
Health Professional from ITALY reported IMATINIB problem on Dec 03, 2007. Male patient, 67 years of age, was diagnosed with chronic myeloid leukaemia and was treated with IMATINIB. After drug was administered, patient experienced the following problems/side effects: aplasia, biopsy bone marrow abnormal, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, bone marrow necrosis, erythroblast count increased, hyperpyrexia, pain in extremity, . IMATINIB dosage: 600 MG/D. Patient recovered.
BIOPSY BONE MARROW ABNORMAL : Cipro Side Effects Report #5575055-1
CIPRO problem was reported by a Health Professional from UNITED STATES on Dec 21, 2007. Female patient, 50 years of age, weighting 186.4 lb, was diagnosed with peritonitis bacterial, prophylaxis and was treated with CIPRO. After drug was administered, patient experienced the following problems/side effects: abdominal distension, biopsy bone marrow abnormal, confusional state, dyspnoea, hypersplenism, neutropenia, white blood cell count decreased, . CIPRO dosage: unknown. Patient recovered.
BIOPSY BONE MARROW ABNORMAL : Zometa Side Effects Report #5483295-5
Physician from JAPAN reported ZOMETA problem on Oct 04, 2007. Male patient, 80 years of age, was diagnosed with bone lesion, multiple myeloma and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: anaemia, biopsy bone marrow abnormal, bone debridement, bone disorder, cataract operation, diarrhoea, facial palsy, loose tooth, multiple myeloma, . ZOMETA dosage: 4 MG EVERY 4 WEEKS. During the same period patient was treated with ALKERAN, PREDONINE, FAMOTIDINE, LOXONIN, SELBEX, TERNELIN, VITAMEDIN CAPSULE, FOLIAMIN. Patient was hospitalized. Patient recovered.
BIOPSY BONE MARROW ABNORMAL : Neulasta Side Effects Report #5447414-9
NEULASTA problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 30, 2007. Female patient, 68 years of age, was diagnosed with anaemia of malignant disease and was treated with NEULASTA. After drug was administered, patient experienced the following problems/side effects: aplasia pure red cell, biopsy bone marrow abnormal, fatigue, feeling cold, incorrect dose administered, influenza like illness, loss of consciousness, malaise, megakaryocytes increased, . NEULASTA dosage: unknown. During the same period patient was treated with ARANESP, NEUPOGEN, CYCLOPHOSPHAMIDE, FOLIC ACID, FERROUS SULPHATE, RITUXIMAB. Patient was hospitalized. Patient recovered.
BIOPSY BONE MARROW ABNORMAL : Zometa Side Effects Report #5449596-1
Physician from JAPAN reported ZOMETA problem on Sept 04, 2007. Male patient, 80 years of age, was diagnosed with bone lesion, multiple myeloma and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: anaemia, biopsy bone marrow abnormal, bone debridement, bone disorder, cataract operation, diarrhoea, facial palsy, loose tooth, multiple myeloma, . ZOMETA dosage: 4 MG EVERY 4 WEEKS. During the same period patient was treated with ALKERAN, PREDONINE, FAMOTIDINE, LOXONIN, SELBEX, TERNELIN, VITAMEDIN CAPSULE, FOLIAMIN. Patient was hospitalized. Patient recovered.
BIOPSY BONE MARROW ABNORMAL : Cytarabine Side Effects Report #5469455-8
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 25, 2007. Female patient, weighting 130.1 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: anorexia, biopsy bone marrow abnormal, cholelithiasis, colitis, diarrhoea, haematochezia, malnutrition, nausea, oral intake reduced, . CYTARABINE dosage: 1162 MG. During the same period patient was treated with DAUNORUBICIN. Patient recovered.
BIOPSY BONE MARROW ABNORMAL : Revlimid Side Effects Report #5423015-3
Physician from UNITED STATES reported REVLIMID problem on Aug 14, 2007. Male patient, 65 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: asthenia, biopsy bone marrow abnormal, disease progression, epistaxis, fatigue, hypercalcaemia, hyponatraemia, malaise, multiple myeloma, . REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL; 15-10MG, DAILY, ORAL; 5 MG, 1 IN 1 D, ORAL. Patient died on 06/17/2007.
BIOPSY BONE MARROW ABNORMAL : Voltaren Side Effects Report #5424648-0
VOLTAREN problem was reported by a Consumer or non-health professional from AUSTRIA on Aug 17, 2007. Male patient was diagnosed with sciatica and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: anaemia, biopsy bone marrow abnormal, prostatic specific antigen increased, . VOLTAREN dosage: 50 MG, UNK. Patient was hospitalized. Patient recovered.
BIOPSY BONE MARROW ABNORMAL : Clarithromicina Side Effects Report #5430911-X
Health Professional from TURKEY reported CLARITHROMICINA RANBAXY problem on Aug 13, 2007. Female patient, 65 years of age, was treated with CLARITHROMICINA RANBAXY. After drug was administered, patient experienced the following problems/side effects: aplastic anaemia, biopsy bone marrow abnormal, cardio-respiratory arrest, pancytopenia, toxic epidermal necrolysis, . CLARITHROMICINA RANBAXY dosage: unknown. During the same period patient was treated with CEFTAZIDIME PENTAHYDRATE, METHYLPREDNISOLONE, IMIPENEM, AMIKACIN SULPHATE. Patient was hospitalized. Patient died.
BIOPSY BONE MARROW ABNORMAL : Cytarabine Side Effects Report #5378382-6
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on July 02, 2007. Female patient, weighting 130.1 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: anorexia, biopsy bone marrow abnormal, blast cells present, cholelithiasis, colitis, febrile neutropenia, malnutrition, oral intake reduced, . CYTARABINE dosage: 1162 MG. During the same period patient was treated with DAUNORUBICIN, MYLOTARG. Patient recovered.
BIOPSY BONE MARROW ABNORMAL : Imatinib Side Effects Report #5394985-7
Health Professional from ITALY reported IMATINIB MESYLATE problem on July 12, 2007. Male patient, 67 years of age, was diagnosed with chronic myeloid leukaemia and was treated with IMATINIB MESYLATE. After drug was administered, patient experienced the following problems/side effects: aplasia, biopsy bone marrow abnormal, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, bone marrow necrosis, erythroblast count increased, hyperpyrexia, pain in extremity, . IMATINIB MESYLATE dosage: 600 MG/D. Patient recovered.
BIOPSY BONE MARROW ABNORMAL : Thalidomide Side Effects Report #5397244-1
THALIDOMIDE problem was reported by a Physician from UNITED KINGDOM on July 12, 2007. Male patient, 74 years of age, was diagnosed with leukaemia plasmacytic and was treated with THALIDOMIDE. After drug was administered, patient experienced the following problems/side effects: angiocentric lymphoma, biopsy bone marrow abnormal, blood immunoglobulin a increased, blood lactate dehydrogenase increased, blood viscosity increased, cardiomegaly, chest discomfort, chest x-ray abnormal, condition aggravated, . THALIDOMIDE dosage: 50 MG, 1 IN 1 D, ORAL. During the same period patient was treated with VELCADE, VINCRISTINE, BENDAMUSTIN, ADRIAMYCIN PFS, PLAVIX, METOPROLOL SUCCINATE. Patient was hospitalized. Patient died on 06/14/2007.
BIOPSY BONE MARROW ABNORMAL : Cytarabine Side Effects Report #5378382-6
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on July 02, 2007. Female patient, weighting 130.1 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: anorexia, biopsy bone marrow abnormal, blast cells present, cholelithiasis, colitis, febrile neutropenia, malnutrition, oral intake reduced, . CYTARABINE dosage: 1162 MG. During the same period patient was treated with DAUNORUBICIN, MYLOTARG. Patient recovered.
BIOPSY BONE MARROW ABNORMAL : Imatinib Side Effects Report #5394985-7
IMATINIB MESYLATE problem was reported by a Health Professional from ITALY on July 12, 2007. Male patient, 67 years of age, was diagnosed with chronic myeloid leukaemia and was treated with IMATINIB MESYLATE. After drug was administered, patient experienced the following problems/side effects: aplasia, biopsy bone marrow abnormal, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, bone marrow necrosis, erythroblast count increased, hyperpyrexia, pain in extremity, . IMATINIB MESYLATE dosage: 600 MG/D. Patient recovered.
BIOPSY BONE MARROW ABNORMAL : Thalidomide Side Effects Report #5397244-1
Physician from UNITED KINGDOM reported THALIDOMIDE problem on July 12, 2007. Male patient, 74 years of age, was diagnosed with leukaemia plasmacytic and was treated with THALIDOMIDE. After drug was administered, patient experienced the following problems/side effects: angiocentric lymphoma, biopsy bone marrow abnormal, blood immunoglobulin a increased, blood lactate dehydrogenase increased, blood viscosity increased, cardiomegaly, chest discomfort, chest x-ray abnormal, condition aggravated, . THALIDOMIDE dosage: 50 MG, 1 IN 1 D, ORAL. During the same period patient was treated with VELCADE, VINCRISTINE, BENDAMUSTIN, ADRIAMYCIN PFS, PLAVIX, METOPROLOL SUCCINATE. Patient was hospitalized. Patient died on 06/14/2007.
BIOPSY BONE MARROW ABNORMAL : Natalizumab Side Effects Report #5565338-3
NATALIZUMAB problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 28, 2007. Female patient, 62 years of age, weighting 170.4 lb, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, aneurysm, biopsy bone marrow abnormal, blepharitis, cognitive disorder, disorientation, dizziness, dysphagia, hepatitis, . NATALIZUMAB dosage: 300 MG;QM;IV. During the same period patient was treated with NEURONTIN, DETROL, MIRAPEX, VYTORIN, SYNTHROID, HYDROCHLOROTHIAZIDE, FOSAMAX, DARVOCET. Patient was hospitalized. Patient recovered.
BIOPSY BONE MARROW ABNORMAL : Clomiphene Side Effects Report #5420156-1
Consumer or non-health professional from JAPAN reported CLOMIPHENE CITRATE problem on Aug 02, 2007. Female patient, 31 years of age, weighting 98.99 lb, was treated with CLOMIPHENE CITRATE. After drug was administered, patient experienced the following problems/side effects: aplasia pure red cell, ascites, biopsy bone marrow abnormal, bone marrow failure, haemoconcentration, hyponatraemia, ovarian hyperstimulation syndrome, pregnancy, . CLOMIPHENE CITRATE dosage: unknown. During the same period patient was treated with MENOTROPINS, CHORIONIC GONADTROPIN. Patient was hospitalized. Patient recovered.